{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:10:31Z","timestamp":1791137431924,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.amjcard.2018.10.032","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T02:21:06Z","timestamp":1541470866000},"page":"507-512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Prevention of Diabetes Mellitus in Patients With Prediabetes"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-5034","authenticated-orcid":false,"given":"Nicholas W.","family":"Carris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R.","family":"Magness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur J.","family":"Labovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.10.032_bib0001","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0002","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/j.jacc.2017.09.001","article-title":"How low to go with glucose, cholesterol, and blood pressure in primary prevention of CVD","volume":"70","author":"Hong","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0003","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0004","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamainternmed.2016.2952","article-title":"What we don't talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage","volume":"176","author":"Spencer Bonilla","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0006","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3122\/jabfm.2016.02.150252","article-title":"Prediabetes diagnosis and treatment in primary care","volume":"29","author":"Mainous","year":"2016","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0007","series-title":"National Diabetes Statistics Report, 2017","year":"2017"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0008","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2337\/dc16-1509","article-title":"Metformin use in prediabetes among U.S. adults, 2005-2012","volume":"40","author":"Tseng","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0009","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.2337\/dc18-S005","article-title":"5. prevention or delay of type 2 diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0010","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4158\/CS-2017-0153","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College Of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary","volume":"24","author":"Garber","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0012","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2337\/dc16-0873","article-title":"Update and next steps for real-world translation of interventions for type 2 diabetes prevention: reflections from a diabetes care editors' expert forum","volume":"39","author":"Cefalu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0013","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/M14-1773","article-title":"Metformin prescription for insured adults with prediabetes from 2010 to 2012: a retrospective cohort study","volume":"162","author":"Moin","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0014","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.japh.2017.04.008","article-title":"Metformin prescribing in low-income and insured patients with prediabetes","volume":"57","author":"Wu","year":"2017","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3122\/jabfm.2016.06.160138","article-title":"Prediabetes screening and treatment in diabetes prevention: the impact of physician attitudes","volume":"29","author":"Mainous","year":"2016","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0016","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s11606-017-4103-1","article-title":"Survey of primary care providers' knowledge of screening for, diagnosing and managing prediabetes","volume":"32","author":"Tseng","year":"2017","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0017","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS","volume":"35","author":"Herman WH","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0018","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2337\/dc16-2099","article-title":"A national effort to prevent type 2 diabetes: participant-level evaluation of CDC's national diabetes prevention program","volume":"40","author":"Ely","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0019","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0020","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1001\/jamainternmed.2016.6210","article-title":"The medicalization of Common conditions","volume":"176","author":"Redberg","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0021","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/jamainternmed.2016.5919","article-title":"Prediabetes risk in adult Americans according to a risk test","volume":"176","author":"Shahraz","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0022","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/S0140-6736(17)30315-X","article-title":"Treating prediabetes in the obese: are GLP-1 analogues the answer?","volume":"389","author":"Farr","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0023","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jama.1963.03060120008005","article-title":"Prediabetes' research - A means to eventual prevention of diabetes","volume":"185","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0024","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S2213-8587(18)30027-5","article-title":"Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014","volume":"6","author":"Ali","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0025","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0026","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. preventive services task force recommendation statement","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0027","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2337\/dc18-S010","article-title":"10. Microvascular Complications and foot care: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0028","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.116.025483","article-title":"Effect of long-term metformin and lifestyle in the diabetes prevention program and its outcome study on coronary artery calcium","volume":"136","author":"Goldberg","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0029","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2337\/dc16-2271","article-title":"Early glycemic control and magnitude of hba1c reduction predict cardiovascular events and mortality: population-based cohort study of 24,752 metformin initiators","volume":"40","author":"Svensson","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0030","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0031","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0032","first-page":"52976","article-title":"Medicare program; revisions to payment policies under the physician fee schedule and other revisions to part B for CY 2018; medicare shared savings program requirements; and medicare diabetes prevention program","volume":"82","year":"2017","journal-title":"Federal Register"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0033","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S2213-8587(15)00391-5","article-title":"Preventing new-onset diabetes in thiazide-treated patients","volume":"4","author":"Mancia","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0034","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.10.032_bib0035","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918320472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918320472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:28:59Z","timestamp":1757572139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918320472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S0002914918320472"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.10.032","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of Diabetes Mellitus in Patients With Prediabetes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}